Sudarshan Pharma Industries share news, announcements and annual reports
NSE: SUDARSHANBSE: 543828Chemicals & PetrochemicalsSmall Cap
Sudarshan Pharma Industries Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2023
Last close ₹36.42down ₹1.06 (2.83%)BSE ₹35.84
Share price at the NSE close on 30 Oct 2026. Previous close ₹37.48.
30 Oct: open ₹39.04, high ₹39.29, low ₹34.70
52-week range of BSE trades to 30 Oct 2026
₹18.50Low, 29 Jan 2026₹42.79High, 21 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹927 Cr1,697th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 31.93
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.74
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 10.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 1.99
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,84,31446.6% delivered
Sudarshan Pharma Industries board meetings
60 filed, newest first. Page 1 of 2.
Oct 2026
Aug 2026
10 Aug · Board meeting
Meeting on 12 Aug 2026: quarterly results
Jun 2026
15 Jun · Board meeting
Meeting on 18 Jun 2026: issue of warrants
May 2026
18 May · Board meeting
Meeting on 21 May 202612 May · Board meeting
Meeting on 15 May 2026
Apr 2026
27 Apr · Board meeting
Meeting on 30 Apr 2026: audited results
Jan 2026
22 Jan · Board meeting
Meeting on 28 Jan 2026: quarterly results
Oct 2025
15 Oct · Board meeting
Meeting on 18 Oct 2025: half yearly results
Aug 2025
11 Aug · Board meeting
Meeting on 14 Aug 2025: quarterly results
Jun 2025
16 Jun · Board meeting
Meeting on 19 Jun 2025: annual general meeting
Apr 2025
21 Apr · Board meeting
Meeting on 24 Apr 2025: audited results
Jan 2025
6 Jan · Board meeting
Meeting on 10 Jan 2025: issue of warrants
Dec 2024
18 Dec · Board meeting
Meeting on 18 Dec 202418 Dec · Board meeting
Oct 2024
25 Oct · Board meeting
Meeting on 31 Oct 2024: half yearly results
Sep 2024
24 Sep · Board meeting
Meeting on 30 Sep 2024: stock split
Jul 2024
1 Jul · Board meeting
Meeting on 4 Jul 2024: issue of warrants
May 2024
21 May · Board meeting
Meeting on 27 May 2024: audited results
Mar 2024
22 Mar · Board meeting
Meeting on 28 Mar 2024
Dec 2023
12 Dec · Board meeting
Meeting on 12 Dec 2023
Nov 2023
3 Nov · Board meeting
Meeting on 10 Nov 2023: employees stock option plan and half yearly results
Aug 2023
14 Aug · Board meeting
Meeting on 18 Aug 2023